Momenta Pharmaceuticals Profile

USD 0.40  2.17%

Sale by Sasisekharan Ram of 100 shares of Momenta Pharmaceuticals

Momenta Pharmaceuticals Inc insider trading alert for sale of common stock by Sasisekharan Ram, the corporate stakeholder, on March 19, 2018. This event was filed by Momenta Pharmaceuticals I with SEC on 2006-05-17. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

Momenta Pharmaceuticals Summary

Momenta Pharmaceuticals Inc (MNTA) is traded on NASDAQ in USA. It is located in MASSACHUSETTS, U.S.A and employs 279 people. Momenta Pharmaceuticals is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under '' category with current market capitalization of 0. Momenta Pharmaceuticals Inc conducts business under Healthcare sector and is part of Drugs - Generic industry. This company has 76.63 M outstanding shares of which 7.08 M shares are now shorted by private and institutional investors with about 10.3 trading days to cover. MOMENTA PHARMA currently holds about 342.67 M in cash with (30.36 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.61.
Check Momenta Pharmaceuticals Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Fmr LlcCommon Shares11.5 M159.8 M
Blackrock IncCommon Shares10.5 M146.1 M
View Momenta Pharmaceuticals Diagnostics

Selected Momenta Pharmaceuticals Inc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Momenta Pharmaceuticals Against Markets

Current Ratings

Momenta Pharmaceuticals 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
< 41% 
Equity ratings for Momenta Pharmaceuticals Inc are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Momenta Pharmaceuticals, Inc., a biotechnology company, focuses on developing generic versions of complex drugs, biosimilars, and novel therapeutics for autoimmune diseases in the United States. Momenta Pharmaceuticals, Inc. was founded in 2001 and is headquartered in Cambridge, Massachusetts. Momenta Pharmaceuticals operates under Drugs - Generic classification in USA and traded on NASDAQ. It employs 279 people. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameMomenta Pharmaceuticals Inc
CEOCraig WheelerView All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
InstrumentUSA Stock View All
RegionNorth America
Business Address675 West Kendall Street
CIK Number01235010.0
IndustryDrugs - Generic
Contact Number617 491 9700
CurrencyUSD - US Dollar


Momenta Pharmaceuticals Analyst Recommendations
Target PriceAdvice# of Analysts
Momenta Pharmaceuticals Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Momenta Pharmaceuticals Analyst Advice  


Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  


Momenta Pharmaceuticals Earnings Estimates
EPSEstimate Date
Quarterly Estimate-0.23February 21, 2017
Momenta Pharmaceuticals Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate  


Momenta Pharmaceuticals Corporate Directors
Bennett Shapiro Independent Director
Georges Gemayel Director, Ph.D
Elizabeth Stoner Independent Director